Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

卡全 - NMPA Drug Approval Details

Approvals/NMPA/Fat Emulsion,Amino Acids(17) and Glucose(19%) Injection

Approved

化学药品

Fat Emulsion,Amino Acids(17) and Glucose(19%) Injection

Fresenius Kabi AB🇨🇳 National Medical Products Administration

Approval Date: Jul 3, 2023
Approval ID: 8VIZZAcfFDq
Company: Fresenius Kabi AB
Type: 化学药品

Approval Details

Approval Id: 8VIZZAcfFDq
Approval Number: 国药准字HJ20130855
Generic Name: 脂肪乳氨基酸(17)葡萄糖(19%)注射液
Generic Name En: Fat Emulsion,Amino Acids(17) and Glucose(19%) Injection
Trade Name: 卡全
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 1540ml [脂肪乳注射液(20%)300ml;复方氨基酸注射液(17)450ml;葡萄糖注射液(19%)790ml]
Reg Date: 2023-07-03
Expired Date: 2028-07-02
Company Name: Fresenius Kabi AB
Production Company Name: Fresenius Kabi AB
Company Detail Path: /organization/fresenius-kabi-ab
Production Company Detail Path: /organization/fresenius-kabi-ab

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jul 3, 2023

Approval ID

8VIZZAcfFDq

Type

化学药品

Back to NMPA Approvals